These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

377 related items for PubMed ID: 1678027

  • 1. Donor hearts with impaired hemodynamics. Benefit of warm substrate-enriched blood cardioplegic solution for induction of cardioplegia during cardiac harvesting.
    Tixier D, Matheis G, Buckberg GD, Young HH.
    J Thorac Cardiovasc Surg; 1991 Aug; 102(2):207-13; discussion 213-4. PubMed ID: 1678027
    [Abstract] [Full Text] [Related]

  • 2. Warm induction of cardioplegia with glutamate-enriched blood in coronary patients with cardiogenic shock who are dependent on inotropic drugs and intra-aortic balloon support.
    Rosenkranz ER, Buckberg GD, Laks H, Mulder DG.
    J Thorac Cardiovasc Surg; 1983 Oct; 86(4):507-18. PubMed ID: 6621080
    [Abstract] [Full Text] [Related]

  • 3. Benefits of normothermic induction of blood cardioplegia in energy-depleted hearts, with maintenance of arrest by multidose cold blood cardioplegic infusions.
    Rosenkranz ER, Vinten-Johansen J, Buckberg GD, Okamoto F, Edwards H, Bugyi H.
    J Thorac Cardiovasc Surg; 1982 Nov; 84(5):667-77. PubMed ID: 7132406
    [Abstract] [Full Text] [Related]

  • 4. Studies of myocardial protection in the immature heart. V. Safety of prolonged aortic clamping with hypocalcemic glutamate/aspartate blood cardioplegia.
    Kofsky E, Julia P, Buckberg GD, Young H, Tixier D.
    J Thorac Cardiovasc Surg; 1991 Jan; 101(1):33-43. PubMed ID: 1986168
    [Abstract] [Full Text] [Related]

  • 5. Safety of prolonged aortic clamping with blood cardioplegia. III. Aspartate enrichment of glutamate-blood cardioplegia in energy-depleted hearts after ischemic and reperfusion injury.
    Rosenkranz ER, Okamoto F, Buckberg GD, Robertson JM, Vinten-Johansen J, Bugyi HI.
    J Thorac Cardiovasc Surg; 1986 Mar; 91(3):428-35. PubMed ID: 3951246
    [Abstract] [Full Text] [Related]

  • 6. Influence of the pH of cardioplegic solutions on intracellular pH, high-energy phosphates, and postarrest performance. Protective effects of acidotic, glutamate-containing cardioplegic perfusates.
    Bernard M, Menasche P, Canioni P, Fontanarava E, Grousset C, Piwnica A, Cozzone P.
    J Thorac Cardiovasc Surg; 1985 Aug; 90(2):235-42. PubMed ID: 2410746
    [Abstract] [Full Text] [Related]

  • 7. The immature and the mature myocardium. Responses to multidose crystalloid cardioplegia.
    Magovern JA, Pae WE, Miller CA, Waldhausen JA.
    J Thorac Cardiovasc Surg; 1988 Apr; 95(4):618-24. PubMed ID: 3352295
    [Abstract] [Full Text] [Related]

  • 8. Glutamate-blood cardioplegia improves ATP preservation in human myocardium.
    Pisarenko OI, Portnoy VF, Studneva IM, Arapov AD, Korostylev AN.
    Biomed Biochim Acta; 1987 Apr; 46(6):499-504. PubMed ID: 2890348
    [Abstract] [Full Text] [Related]

  • 9. Studies on prolonged acute regional ischemia. III. Early natural history of simulated single and multivessel disease with emphasis on remote myocardium.
    Beyersdorf F, Acar C, Buckberg GD, Partington MT, Sjöstrand F, Young HH, Bugyi HI, Okamoto F, Allen BS.
    J Thorac Cardiovasc Surg; 1989 Sep; 98(3):368-80. PubMed ID: 2770319
    [Abstract] [Full Text] [Related]

  • 10. Protection of the hypertrophied pig myocardium. A comparison of crystalloid, blood, and Fluosol-DA cardioplegia during prolonged aortic clamping.
    Novick RJ, Stefaniszyn HJ, Michel RP, Burdon FD, Salerno TA.
    J Thorac Cardiovasc Surg; 1985 Apr; 89(4):547-66. PubMed ID: 3157028
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Continuous warm versus intermittent cold cardioplegic infusion: a comparison of energy metabolism, sodium-potassium adenosine triphosphatase activity, and postischemic functional recovery in the blood-perfused rat heart.
    Qiu Y, Galiñanes M, Haddock PS, Hcarse DJ.
    J Thorac Cardiovasc Surg; 1996 Sep; 112(3):797-805. PubMed ID: 8800170
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Brain death-induced cardiac contractile dysfunction and long-term cardiac preservation. Rat heart studies of the effects of hypophysectomy.
    Galiñanes M, Smolenski RT, Hearse DJ.
    Circulation; 1993 Nov; 88(5 Pt 2):II270-80. PubMed ID: 8222165
    [Abstract] [Full Text] [Related]

  • 16. Effects of supplemental L-arginine during warm blood cardioplegia.
    Hayashida N, Tomoeda H, Oda T, Tayama E, Chihara S, Akasu K, Kosuga T, Kai E, Aoyagi S.
    Ann Thorac Cardiovasc Surg; 2000 Feb; 6(1):27-33. PubMed ID: 10748356
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. The effect of temperature and hematocrit level of oxygenated cardioplegic solutions on myocardial preservation.
    Rousou JA, Engelman RM, Breyer RH, Otani H, Lemeshow S, Das DK.
    J Thorac Cardiovasc Surg; 1988 Apr; 95(4):625-30. PubMed ID: 3352296
    [Abstract] [Full Text] [Related]

  • 19. Long-term preservation of donor hearts: the effect of intra- and extracellular-type of cardioplegic solutions on myocardial high energy phosphate content.
    Dyszkiewicz W, Minten J, Flameng W.
    Mater Med Pol; 1990 Apr; 22(3):147-52. PubMed ID: 2132419
    [Abstract] [Full Text] [Related]

  • 20. Studies of controlled reperfusion after ischemia. XIX. Reperfusate composition: benefits of blood cardioplegia over fluosol DA cardioplegia during regional reperfusion--importance of including blood components in the initial reperfusate.
    Acar C, Partington MT, Buckberg GD.
    J Thorac Cardiovasc Surg; 1991 Feb; 101(2):284-93. PubMed ID: 1992239
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.